Health Catalyst, Inc.

Technology
Computer Software: Programming, Data Processing
www.healthcatalyst.com

Moat Score
Safety Score

Market Cap $496.40M
PE -6
Debt $585.42M
Cash $328.33M
EV $753.49M
FCF -$2.41M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$79.14M
EBIT	-$91.70M
ROE	-22%
ROA	-11%
FCF	-$2.41M
Equity	$355.04M
Growth Stability	1
PE	-6.27
PB	1.4
P/FCF	-205.72
P/S	1.64
Price/Cash	0.66
Debt/Equity	1.65
Debt/FCF	-242.61
Net Margins	-22%
Gross Margins	45%
Op. Margins	-30%
Sales Growth YoY	3%
Sales Growth QoQ	1%
Sales CAGR	20%
Equity CAGR	13%
Earnings Growth YoY	-33%

Earnings Growth QoQ	9%
Sales CAGR 5Y	16%
Equity CAGR 5Y	12%
Earnings CAGR 3Y	8%
Sales CAGR 3Y	8%
Equity CAGR 3Y	-13%
Market Cap	$496.40M
Revenue	$302.06M
Assets	$813.05M
Total Debt	$585.42M
Cash	$328.33M
Shares Outstanding	59.45M
EV	753.49M
Moat Score	3%
Safety Score	67%
Working Capital	133.63M
Current Ratio	1.41
Gross Profit	$136.60M
Shares Growth 3y	6%
Equity Growth QoQ	-1%
Equity Growth YoY	-7%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

SEC Filings

Direct access to Health Catalyst, Inc. (HCAT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Health Catalyst, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Health Catalyst, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Health Catalyst, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Health Catalyst, Inc..

Years

Calculation mode

= -$24M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$2.4M	-$24M
DCF		-$2.2M	-$2M	-$1.8M	-$1.6M	-$1.5M	-$1.4M	-$1.2M	-$1.1M	-$1M	-$930K	-$9.3M
Value	-$24M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	-80%	-101%	-155%	-61%	-63%	-50%	-40%	-22%
ROA	-	-	-18%	-17%	-17%	-19%	-18%	-11%
ROE	-	-	-120%	-42%	-29%	-32%	-32%	-22%

Bad Net Margins (-21.51%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-1.39	-4.98	-5.39	-6.05	-6.7	-242.61
Debt over Equity	-	-0.05	0.24	0.61	0.35	0.53	0.63	1.65
Growth Stability	-	-	-	-	-	-	-	1

Good Debt/FCF ratio (-242.61)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Bad Debt/Equity ratio (1.65)

The company is overleveraged and has a bad balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	54%	38%	22%	28%	14%	7%	16%
Earnings YoY growth	-	94%	111%	-52%	33%	-10%	-14%	-
Equity YoY growth	-	44%	-154%	38%	89%	-19%	-14%	12%
FCF YoY growth	-	8%	-19%	-2%	-1%	12%	-8%	-